Brief: NRx Pharmaceuticals Announces Submission Of An Investigational New Drug Application For NRX-101 In The Treatment Of Chronic Pain

NRX Pharmaceuticals

30/08/2023 12:01

Aug 30 (Reuters) - NRX Pharmaceuticals Inc  NRXP.O :
    * NRX PHARMACEUTICALS ANNOUNCES SUBMISSION OF AN
INVESTIGATIONAL
NEW DRUG (IND) APPLICATION FOR NRX-101 IN THE TREATMENT OF
CHRONIC PAIN
    * NRX PHARMACEUTICALS INC - DATA COLLECTION IS COMPLETE AND
STATISTICAL RESULTS ARE EXPECTED IN COMING MONTHS
    * NRX PHARMACEUTICALS- PLAN TO SEEK FAST TRACK DESIGNATION,
PRIORITY REVIEW, BREAKTHROUGH THERAPY DESIGNATION FOR USE OF
NRX-101 TO TREAT CHRONIC PAIN
    * NRX PHARMACEUTICALS- HAVE SUFFICIENT QUANTITIES OF OUR
INVESTIGATIONAL DRUG ON HAND TO LAUNCH REGISTRATIONAL STUDIES IN
2024

Source text for Eikon:  ID:nPn88mzjza 
Further company coverage:  NRXP.O